The document is a confidential presentation by Leonardo & Co. for Project Zermatt, detailing the investment rationale, financials, and proposed terms for the acquisition and combination of Farmabios and PharmaZell by Ergon Capital Partners. It includes financial projections, company overviews, and proposed equity structures.
documents/EFTA01077699.pdf
{}